Open an account

Cencora

COR · NYSE

$343.27+$3.27 (+0.96%)TodayMarket closed ·
Prev close $340.00

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Employees
49,000
Headquarters
Conshohocken, Pennsylvania
Listed
May 28, 1996
Sector
Health Care
Industry
Health Care Providers & Services
Website
cencora.com

COR key statistics

Market cap
64.88B
Price-earnings ratio
25.24
Dividend yield
0.72%
Average volume
1.19M
Volume
916.81K
Open price
$343.50
High today
$345.00
Low today
$339.53
52 Week high
$377.54
52 Week low
$244.82

Cencora (COR) at a glance

As of Oct 20, 2026, Cencora (COR) shares are priced at $343.27, giving the company a market cap of 64.88B, a price-to-earnings ratio of 25.24 and a dividend yield of 0.72%.

Today the stock has traded between $339.53 and $345.00. The current price is 1.1% above the day's low and 0.5% below its high.

Volume so far is 916.81K shares, below the average of 1.19M shares a day.

Over the past year Cencora has ranged from $244.82 to $377.54, and now sits 74% of the way up that range.

Cencora met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $4.48 per share against an estimate of $4.39.

The average analyst price target is $373.21, 8.7% above the current price, from 16 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

81%of 16 analyst ratings say Buy
  • Buy81.3%
  • Hold18.8%
  • Sell0.0%
Price target · 15 analystsAvg $373.21
Low
$333.30
Now
$343.27
High
$451.50

COR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 3.3% on average.

  1. Q3 FY24: reported $3.34 per share against an estimate of $3.25
  2. Q4 FY24: reported $3.34 per share against an estimate of $3.25
  3. Q1 FY25: reported $3.73 per share against an estimate of $3.54
  4. Q2 FY25: reported $4.42 per share against an estimate of $4.15
  5. Q3 FY25: reported $4.00 per share against an estimate of $3.88
  6. Q4 FY25: reported $3.84 per share against an estimate of $3.82
  7. Q1 FY26: reported $4.75 per share against an estimate of $4.86
  8. Q2 FY26: reported $4.48 per share against an estimate of $4.39

COR news

  • Press releaseBusiness Wire

    Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

  • Press releaseBusiness Wire

    Cencora Elects Robert E. Sanchez to Its Board of Directors

  • Mohd Haider

    Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls Payout ‘Immaterial’

  • Piero Cingari

    Terrible Jobs Report Sparks Rally In AI and Tech: 10 Stocks Leading Friday's Surge

  • Vandana Singh

    Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins

  • Press releaseBusiness Wire

    Cencora Reports Fiscal 2026 Third Quarter Results

  • 'FTC Takes Closer Look at Merger of Vet Products Distributors' - Bloomberg

  • Press releaseBusiness Wire

    Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release

Similar companies

Companies in the same industry as Cencora

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.